Financial Performance - The company's operating revenue for Q1 2021 was ¥418,291,194.67, representing a 27.73% increase compared to ¥327,478,471.48 in the same period last year[8] - The net profit attributable to shareholders was a loss of ¥6,616,555.53, an improvement of 61.73% from a loss of ¥17,287,197.92 in the previous year[8] - The basic and diluted earnings per share were both -¥0.0088, showing a 61.74% improvement from -¥0.0230 in the previous year[8] - The company's net loss for the period was CNY 1,050,968,533.30, worsening from a loss of CNY 1,037,645,428.90 in the previous period[46] - The company reported a net profit of -510,999.49, a significant improvement from -12,418,377.97 in the previous period, indicating a recovery trend[50] - The company reported a total comprehensive income of -510,999.49, compared to -12,418,377.97 in the previous period, showing a positive trend[51] Cash Flow - The net cash flow from operating activities was ¥26,668,686.45, a significant increase of 227.43% compared to a negative cash flow of ¥20,927,363.42 in the same period last year[8] - Total cash inflow from operating activities was ¥485,233,131.17, while cash outflow was ¥458,564,444.72, resulting in a positive net cash flow[58] - The cash flow from operating activities for the parent company was ¥19,695,727.52, a notable increase from ¥5,987,910.11 in the previous year[60] - The company reported a total cash outflow of ¥97,430,273.20 from operating activities for the parent company, which is lower than the previous year's outflow of ¥109,402,089.89[60] Assets and Liabilities - Total assets at the end of the reporting period were ¥3,382,909,860.97, a decrease of 2.09% from ¥3,455,089,205.24 at the end of the previous year[8] - The total liabilities decreased to CNY 1,200,285,988.65 from CNY 1,165,603,191.26, indicating a reduction in financial obligations[46] - Total liabilities amounted to CNY 1,544,251,332.71, with current liabilities at CNY 1,355,915,954.69[66] - The company recorded an undistributed profit of CNY -685,341,280.98, indicating a loss position[66] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 82,191[11] - The largest shareholder, Gome Holdings Group Co., Ltd., held 27.78% of the shares, amounting to 209,213,228 shares, with 124,101,400 shares pledged[11] - The company did not conduct any repurchase transactions among the top 10 shareholders during the reporting period[12] Operating Costs and Expenses - Operating costs for the period amounted to RMB 176.01 million, an increase of 34.86% year-on-year, mainly due to increased rental payments by a subsidiary[15] - Tax expenses for the period were RMB 9.42 million, an increase of 84.80% year-on-year, attributed to increased revenue from the company and its subsidiaries[15] - Financial expenses for the period were RMB 9.79 million, a decrease of 33.05% year-on-year, mainly due to reduced interest expenses from decreased bank borrowings by a subsidiary[16] - Research and development expenses for Q1 2021 were CNY 8,657,015.74, up from CNY 7,016,388.74 in the previous period, highlighting a focus on innovation[49] Investments and Projects - The company reported non-recurring gains and losses totaling ¥2,500,130.14 for the reporting period[9] - The company has invested CNY 2,100.89 million in a drug metabolism platform project, with CNY 12.00 million spent in the reporting period[31] - The company reported an investment income of CNY 1,444,590.12, a recovery from a loss of CNY 55,984.76 in the previous period[49] - The company plans to apply for financing lease back with production equipment valued at RMB 75 million to optimize its financing structure[23] Future Outlook - Future outlook includes potential market expansion and new product development, although specific strategies were not detailed in the provided data[50] - The company is adjusting its financial statements in accordance with the new leasing standards effective from 2021, which may impact future financial reporting[63]
中关村(000931) - 2021 Q1 - 季度财报